Bath & Body Works, Inc.

Valuation Analysis

About the Company

Bath & Body Works, Inc. en bref

Bath & Body Works, Inc. (BBWI) is currently trading at 17,93 € with a market capitalization of 3,6 Md €. The trailing P/E ratio stands at 5.84x, with a forward P/E of 7.17x. The 52-week range spans from 12,45 € to 29,61 €; the current price is 39.4% below the yearly high. Year-over-year revenue growth stands at -3.2%. The net profit margin stands at 10.04%.

💰 Dividende

Bath & Body Works, Inc. currently does not pay a dividend. The company typically reinvests its earnings into growth initiatives and product development.

📊 Avis des analystes

14 analystes évaluent Bath & Body Works, Inc. (BBWI) au consensus : None. L'objectif de cours moyen est de 22,29 €, soit un potentiel de +24.34% par rapport au cours actuel. La fourchette des objectifs de cours des analystes va de 16,56 € à 47,08 €.

Bath & Body Works, Inc. : la thèse d'investissement en détail

Bath & Body Works, Inc. (BBWI) operates in the Consumer Cyclical — specifically Specialty Retail — and is headquartered in United States. Below is a structured read of the investment case built directly from the latest fundamentals, valuation multiples, analyst positioning and smart-money flows. Each section translates raw numbers into the investment logic they imply, so you can decide whether the risk/reward fits your portfolio.

Le scénario haussier

Earnings growth of 83.7% is outpacing revenue, a sign of operational leverage — fixed costs are being absorbed across a larger base. Our valuation screen flags the stock as undervalued relative to its fundamentals — multiples are running below where the cash flow profile would normally justify.

Le scénario baissier

Revenue is contracting at -3.2% year-over-year — until that trend reverses, valuation is exposed to further downgrades.

Valorisation en contexte

With a PEG ratio of 0.81, the price-to-earnings multiple is actually below the company's growth rate — classic value-meets-growth territory that Peter Lynch would have called a 'GARP' opportunity. The EV/EBITDA multiple of 6.04x is below the historical equity-market average — strategic acquirers would find the cash-flow profile attractive at this level.

À surveiller

• The analyst consensus price target implies 24.34% upside — if the next two quarters confirm the underlying thesis, target hikes typically follow.

Thèse d'investissement : forces et faiblesses

Aperçu technique

The price is in a transition zone relative to the moving averages — no clear signal.

Profil de risque

The data points to market-like volatility, elevated short interest (7.54%).

Trading Data

Related Stocks in the Same Sector

Where can I buy Bath & Body Works, Inc.?

Compare top-rated brokers — low fees, trusted providers, fully regulated.